使用本网站需要启用 JavaScript, 请启用后刷新页面获得更好的体验
登录
注册
首页
个人基因检测
临床应用研究
科研合作项目
合作与服务
社区
研究所
微解读
应用
姓氏祖源
基因关系
原始数据
使用 WeGene 需要启用 Cookies, 请启用后刷新页面获得更好的体验
社区首页
小组
前列腺癌
前列腺癌
发起讨论
前列腺癌
22 个讨论
只看精华帖
按热门排序
按最新排序
来到这里的老哥们
macross
• 最后回复
WeGene_F97B98EE
•
2023-11-28 15:17
2522
7
• 来自相关小组
为什么这么低?
jr17623642959
• 最后回复
dfdtc
•
2021-04-12 13:20
2745
3
• 来自相关小组
祝福我吧,可能是有史以来最高的了。
fanyeyu1416
• 最后回复
Katree
•
2020-03-20 02:16
6840
46
• 来自相关小组
前列腺癌是37.88倍……
英俊的EDN1基因
• 最后回复
steley
•
2019-12-03 09:36
3864
6
• 来自相关小组
5岁40多倍前列腺癌几率?什么鬼
成熟的THSD4基因
• 最后回复
Juicio
•
2019-12-02 13:00
2636
3
• 来自相关小组
你的前列腺还好吗
元月十号
• 最后回复
暗色雷恩
•
2019-11-27 04:05
3179
7
• 来自相关小组
我爸的前列腺癌风险137.72倍????
威武的TBX3基因
• 最后回复
zhengqiang
•
2019-09-13 18:34
2546
2
• 来自相关小组
5倍 这个好准 好怕怕
心软的14号染色体
• 最后回复
大方的CNTN5基因
•
2019-08-07 14:51
2512
2
• 来自相关小组
前列腺癌发病率33倍,我是不是该早点切了…
NoahMZX
• 最后回复
开顺顺
•
2019-03-28 00:01
2743
2
• 来自相关小组
请问我的前列腺还有救吗 现在不敢撒尿 在线等 挺急的
jtyjty
• 最后回复
tiangualhj
•
2018-10-23 18:40
4237
11
• 来自相关小组
我26倍的前列腺癌啊...爷爷爸爸都有前列腺炎
努力的NELL1基因
• 最后回复
starvich
•
2018-08-27 15:12
4799
10
• 来自相关小组
前列腺癌 9.5倍,感觉好可怕
eaohao
• 最后回复
哽咽的GCNT2基因
•
2018-08-23 16:26
2640
1
• 来自相关小组
得病概率这么算对吗?
a80643022
• 最后回复
喝醉的11号染色体
•
2018-07-20 12:57
4123
6
• 来自相关小组
前列腺癌25倍?
macross
• 最后回复
yixiaolan
•
2018-03-08 11:46
4527
12
• 来自相关小组
为什么微基因前列腺癌风险比第三方应用评估小得多?
近视的PTPRD基因
• 最后回复
honglun
•
2018-02-12 22:35
2783
1
• 来自相关小组
求助,前列腺癌风险40几倍,是不是太高了?
TTfanz
• 最后回复
niu308067264
•
2017-11-03 20:50
3232
3
• 来自相关小组
15.59倍,感觉预知了自己的死因
valleytramp
• 最后回复
MrDoubleX
•
2017-08-28 18:40
3458
3
• 来自相关小组
40多倍是不是成必然了
yantonglan
• 最后回复
费力科思
•
2017-07-21 20:43
3020
1
• 来自相关小组
前列腺癌5倍多!
双子的NRXN3基因
• 最后回复
MrDoubleX
•
2017-07-19 16:22
2751
1
• 来自相关小组
20.42 倍,怪不得我从22岁就会疼了(果然以后定期测PSA)
严肃的MAGI2基因
• 最后回复
lily
•
2017-06-13 13:03
4448
8
• 来自相关小组
发起讨论
前列腺癌
22 个讨论
相关基因
CYP1B1
位点:RS1056836
TIMM23B
位点:RS10993994
PCAT19
位点:RS11672691
TOR1A
位点:RS1182
HOXB13
位点:RS138213197
CASC8
位点:RS1447295
FYCO1
位点:RS1545985
位点:RS7652331
DAB2IP
位点:RS1571801
CDH1
位点:RS16260
ATM
位点:RS1800057
CASC17
位点:RS1859962
FGFR4
位点:RS2011077
位点:RS351855
CDKN1B
位点:RS2066827
VDR
位点:RS2107301
MIR548AZ
位点:RS2987983
RFX6
位点:RS339331
HNF1B
位点:RS4430796
CASP8
位点:RS59308963
KIAA1211
位点:RS629242
CCAT2
位点:RS6983267
EHBP1
位点:RS721048
TNRC6B
位点:RS9623117
BCL2L11
位点:RS11691517
PKNOX2
位点:RS138466039
ARHGAP6
位点:RS17321482
SUGCT
位点:RS17621345
RNLS
位点:RS1935581
INCENP
位点:RS2277283
RNF43
位点:RS2680708
RFX7
位点:RS33984059
COL23A1
位点:RS4976790
PPFIBP2
位点:RS61890184
MEIS1-AS3
位点:RS74702681
DOCK2
位点:RS76551843
UHRF1BP1
位点:RS9469899
MOB2
位点:RS1881502
MMP14
位点:RS1004030
ATAT1
位点:RS12665339
CYP1B1 variants are associated with prostate cancer in non-Hispanic and Hispanic Caucasians
Multiple newly identified loci associated with prostate cancer susceptibility
Prostate Cancer (PCa) Risk Variants and Risk of Fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
A Population-based Assessment of Germline HOXB13 G84E Mutation and Prostate Cancer Risk
A common variant associated with prostate cancer in European and African populations
Prostate cancer susceptibility variants confer increased risk of disease progression
Early Onset Prostate Cancer Has A Significant Genetic Component
Comprehensive genetic evaluation of common E-cadherin sequence variants and prostate cancer risk: strong confirmation of functional promoter SNP.
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Chromosome 17q12 variants contribute to risk of early-onset prostate cancer
Gene variants in the angiogenesis pathway and prostate cancer
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.
Estrogen receptor beta polymorphism is associated with prostate cancer risk.
Replication and cumulative effects of GWAS-identified genetic variations for prostate cancer in Asians: a case–control study in the ChinaPCa consortium
Association of FGFR4 Genetic Polymorphisms with Prostate Cancer Risk and Prognosis
Large-scale fine mapping of the HNF1B locus and prostate cancer risk
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Prostate Cancer Susceptibility Variants Confer Increased Risk of Disease Progression
Cumulative Association of Five Genetic Variants with Prostate Cancer
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer
Prostate Cancer Susceptibility Variants Confer Increased Risk of Disease Progression
Sequence variants at 22q13 are associated with prostate cancer risk
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci